Han, Guo-Rong <br/><br/>
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.  [electronic resource] 

 -  Journal of hepatology  Dec 2011 
 - 1215-21 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-0641 
<br/><br/><label>Standard No.: </label>10.1016/j.jhep.2011.02.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>DNA, Viral--blood<br/>Female<br/>Hepatitis B Antibodies--administration & dosage<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B Vaccines--administration & dosage<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B, Chronic--complications<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Infectious Disease Transmission, Vertical--prevention & control<br/>Male<br/>Nucleosides--adverse effects<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Prospective Studies<br/>Pyrimidinones--adverse effects<br/>Telbivudine<br/>Thymidine--analogs & derivatives<br/>Treatment Outcome<br/>Young Adult